Kongpon Tangpanitandee, Worawit Kattipatanapong, Jakrapan Wittayapairoch, Rapheephat Tanompetsanga, Krit Kitisin, Suppa-ut Pungpapong, Chadin Tharavej, Patpong Navicharern, Suthep Udomsawaengsup. Chulalongkorn University
Introduction: Sleeve gastrectomy and gastric bypass are two of effective bariatric procedure in obesity and metabolic disorder. This study aims to evaluate 3-years result of diabetes remission after laparoscopic sleeve gastrectomy (LSG) and laparoscopic Roux-en-Y gastric bypass (LRYGB) in severe obesity type-2 diabetic patients.
Methods: We analyzed 364 severe obesities (BMI over 35 kg/m2) Thai patient’s data who underwent LSG or LRYGB in our center from 2007 to 2015. Among of them, 98 patients had type-2 diabetes preoperatively diagnosed. Medical record reviewed include demographic data, weight change, body mass index, percentage of excess weight loss, level of HbA1c and percentage of diabetes remission patient.
Result: In 98 severe obesity type-2 diabetic patients, including 49 males and 49 females. LSG was performed in 45 patients and 53 patients underwent LRYGB. All patients mean age was 39.8 years, mean BMI was 50.6 kg/m2, mean HbA1C was 8.0%, mean obesity-related comorbidity diagnosed was 90.1% had hypertension, 64.2% had dyslipidemia, and 86.7% had obstructive sleep apnea. Diabetes remission at one year was 71.4% (59% in LSG, 80.8% in LRYGB) and mean HbA1c was 6.0%. At 3-years postoperative follow up (n=39) diabetes remission was 89.7% (80% in LSG, 100% in LRYGB) and mean HbA1c was 5.9%.
Conclusion: Bariatric surgery is safe and long-term effective for type-2 diabetes remission in severe obesity diabetic patients.
Presented at the SAGES 2017 Annual Meeting in Houston, TX.
Abstract ID: 78918
Program Number: P497
Presentation Session: Poster (Non CME)
Presentation Type: Poster
